Evidence map›Paper›PMID 34071907›Full record

ArticlePharmaceutics2021

Optimized Loading of Idarubicin in CalliSpheres

Enhao Lu, Guoliang Shao, Jingqin Ma, Yiwei He, Yuanchuan Gong, Zhiping Yan, Xianyi Sha

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. One-step fabrication of lidocaine/CalliSpheresJournal of translational medicine · 2022
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Enhao LuKey Laboratory of Smart Drug Delivery, Department of Pharmaceutics, School of Pharmacy, Fudan University, Shanghai 201203, China.
Guoliang ShaoCancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou 310022, China.
Jingqin MaInterventional Radiology of Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Yiwei HeCancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou 310022, China.
Yuanchuan GongCancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou 310022, China.
Zhiping YanInterventional Radiology of Zhongshan Hospital, Fudan University, Shanghai 200032, China.ORCID 0000-0002-9352-3526
Xianyi ShaKey Laboratory of Smart Drug Delivery, Department of Pharmaceutics, School of Pharmacy, Fudan University, Shanghai 201203, China.

Funding

National Natural Science Foundation of China 82072032
6 · The paper itself

Abstract

This study aimed to investigate the idarubicin loading method, compatible stability with contrast agent, release profiles, and morphological properties of 50-150, 100-300, and 300-500 μm CalliSpheres

Indexed as

CalliSpheres®idarubiciniopamidol compatibilityloading efficiencymorphologyrelease profiles

Identifiers

PMID34071907
PMCPMC8229965

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.